TW200833687A - Substituted piperidines - Google Patents

Substituted piperidines

Info

Publication number
TW200833687A
TW200833687A TW097113173A TW97113173A TW200833687A TW 200833687 A TW200833687 A TW 200833687A TW 097113173 A TW097113173 A TW 097113173A TW 97113173 A TW97113173 A TW 97113173A TW 200833687 A TW200833687 A TW 200833687A
Authority
TW
Taiwan
Prior art keywords
substituted piperidines
explained
compounds
piperidines
detail
Prior art date
Application number
TW097113173A
Other languages
English (en)
Chinese (zh)
Inventor
Peter Herold
Robert Mah
Vincenzo Tschinke
Michael Quirmbachi
Aleksandar Stojanovic
Dirk Behnke
Christiane Marti
Frank Hollinger
Zenon D Konteatis
Jennifer L Ludington
Stefan Stutz
Stjepan Jelakovic
Original Assignee
Speedel Experimenta Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Speedel Experimenta Ag filed Critical Speedel Experimenta Ag
Publication of TW200833687A publication Critical patent/TW200833687A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
TW097113173A 2005-03-31 2006-03-29 Substituted piperidines TW200833687A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66655605P 2005-03-31 2005-03-31
US75085305P 2005-12-16 2005-12-16

Publications (1)

Publication Number Publication Date
TW200833687A true TW200833687A (en) 2008-08-16

Family

ID=36586065

Family Applications (2)

Application Number Title Priority Date Filing Date
TW097113173A TW200833687A (en) 2005-03-31 2006-03-29 Substituted piperidines
TW095110894A TW200716622A (en) 2005-03-31 2006-03-29 Substituted piperidines

Family Applications After (1)

Application Number Title Priority Date Filing Date
TW095110894A TW200716622A (en) 2005-03-31 2006-03-29 Substituted piperidines

Country Status (13)

Country Link
US (2) US20100029628A1 (enExample)
EP (1) EP1863803B1 (enExample)
JP (2) JP2008534558A (enExample)
AR (2) AR055756A1 (enExample)
AT (1) ATE479681T1 (enExample)
BR (2) BRPI0608758A2 (enExample)
CA (1) CA2601702A1 (enExample)
DE (1) DE602006016573D1 (enExample)
IL (2) IL186130A0 (enExample)
PL (1) PL1863803T3 (enExample)
PT (1) PT1863803E (enExample)
TW (2) TW200833687A (enExample)
WO (1) WO2006103277A2 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2577084A1 (en) 2004-08-25 2006-03-02 Olivier Bezencon Bicyclononene derivatives as renin inhibitors
TW200833687A (en) * 2005-03-31 2008-08-16 Speedel Experimenta Ag Substituted piperidines
AU2006253805A1 (en) 2005-05-27 2006-12-07 Actelion Pharmaceuticals Ltd. Novel piperidine carboxylic acid amide derivatives
GB0514203D0 (en) 2005-07-11 2005-08-17 Novartis Ag Organic compounds
NZ573735A (en) 2006-05-19 2011-10-28 Abbott Lab Cns active fused bicycloheterocycle substituted azabicyclic alkane derivatives
TW200815425A (en) * 2006-06-08 2008-04-01 Speedel Experimenta Ag 2,5-disubstituted piperidines
TW200821303A (en) * 2006-08-08 2008-05-16 Speedel Experimenta Ag Organic compounds
EP1958634A3 (en) * 2007-02-14 2008-09-24 Speedel Experimenta AG Substituted piperidines as inhibitors of beta-secretase, cathepsin D, plasmepsin II and/or HIV protease
TW200922596A (en) * 2007-10-25 2009-06-01 Speedel Experimenta Ag 4,4-disubstituted piperidines
TW200934499A (en) * 2007-11-02 2009-08-16 Speedel Experimenta Ag 4,4-disubstituted piperidines
CA2708866A1 (en) 2007-12-19 2009-06-25 Hiroyuki Nakahira Bicyclic heterocyclic derivative
KR20100131427A (ko) * 2008-02-08 2010-12-15 노파르티스 아게 레닌 억제제로서의 치환된 피페리딘
CA2714347A1 (en) 2008-02-08 2009-08-13 Novartis Ag Substituted piperidines as renin inhibitors
US8889714B2 (en) 2008-05-05 2014-11-18 Actelion Pharmaceuticals Ltd. 3,4-substituted piperidine derivatives as renin inhibitors
EP2163245A1 (en) 2008-09-10 2010-03-17 Novartis Ag Renin inhibitors for the treatment of psoriasis
US8389731B2 (en) * 2009-05-15 2013-03-05 Northwestern University Chiral pyrrolidine core compounds en route to inhibitors of nitric oxide synthase
KR20120109292A (ko) 2009-06-24 2012-10-08 다이닛본 스미토모 세이야꾸 가부시끼가이샤 Ｎ-치환-시클릭 아미노 유도체
HK1246743A1 (zh) * 2015-01-09 2018-09-14 J.W. Speaker Corporation 用於车辆的跟踪和照明系统及方法
DE102015013191A1 (de) * 2015-10-10 2017-04-13 Daimler Ag Verfahren zum Betrieb einer Leuchteinheit und Leuchteinheit

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL193686B1 (pl) * 1995-09-07 2007-03-30 Hoffmann La Roche Pochodne piperydyny, środki lecznicze zawierającepochodne piperydyny, sposoby wytwarzania tych pochodnych oraz zastosowanie pochodnych
US6376672B1 (en) * 1999-04-27 2002-04-23 Hoffmann-La Roche Inc. Naphthalenylmethoxypiperidines as renin inhibitors
US6197959B1 (en) * 1999-04-27 2001-03-06 Hoffmann-La Roche Inc. Piperidine derivatives
US20040204455A1 (en) * 2003-04-10 2004-10-14 Cody Wayne Livingston Piperidine derivative rennin inhibitors
TW200833687A (en) * 2005-03-31 2008-08-16 Speedel Experimenta Ag Substituted piperidines

Also Published As

Publication number Publication date
EP1863803A2 (en) 2007-12-12
JP2008201787A (ja) 2008-09-04
DE602006016573D1 (de) 2010-10-14
JP2008534558A (ja) 2008-08-28
TW200716622A (en) 2007-05-01
PL1863803T3 (pl) 2011-02-28
US20100029628A1 (en) 2010-02-04
AR065188A2 (es) 2009-05-20
PT1863803E (pt) 2010-11-18
EP1863803B1 (en) 2010-09-01
BRPI0621969A2 (pt) 2011-07-19
WO2006103277A3 (en) 2006-12-28
AR055756A1 (es) 2007-09-05
ATE479681T1 (de) 2010-09-15
WO2006103277A2 (en) 2006-10-05
BRPI0608758A2 (pt) 2009-07-07
IL189429A0 (en) 2008-06-05
CA2601702A1 (en) 2006-10-05
US20080171748A1 (en) 2008-07-17
IL186130A0 (en) 2008-01-20
US7687495B2 (en) 2010-03-30

Similar Documents

Publication Publication Date Title
TW200513461A (en) Organische verbindungen
TW200716622A (en) Substituted piperidines
MX2007008137A (es) Triazoloftalazinas como inhibidores de pde2.
ZA200701137B (en) Triazolophthalazines
GEP20094785B (en) Pyrrolopyrazoles, potent kinase inhibitors
NO20075273L (no) Nye forbindelser
GEP20115251B (en) Smac peptidomimetics useful as iap inhibitors
TW200728277A (en) Bicyclic derivatives as P38 inhibitors
IL180242A0 (en) Piperidine derivatives as renin inhibitors
NO20075275L (no) Nye forbindelser
MX2010002245A (es) Derivados de ariloxiacetamida bi o triciclicos, saturados e insaturados y su uso como fungicidas.
EP1881975B8 (en) N,n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors
WO2006072612A3 (en) Triazolophthalazines as pde2- inhibitors
UA94910C2 (ru) Замещенные глицинамиды с антитромбическим действием и ингибирующим действием на фактор ха
PL377124A1 (pl) Pochodne oksamidu użyteczne jako inhibitory kinazy raf
WO2007000340A8 (en) Bicyclic derivatives as p38 kinase inhibitors
TW200700358A (en) Organic compounds
NO20074528L (no) Substituerte pyrroler, sammensetninger, fremgangsmate for fremstilling og anvendelse av samme
ATE512967T1 (de) Als kinaseinhibitoren geeignete pyrrolotriazinverbindungen
BRPI0518277A2 (pt) pirrol[1,2-d][1,2-4]triazina como inibidores de cinases de terminal n de c-jun (jnk) e p-38 cinases
WO2007000337A8 (en) Bicyclic derivatives as p38 kinase inhibitors
MX2008001541A (es) Metodos para la preparacion de inhibidores de polimerasa del vhc.
TW200716130A (en) Purified form of tanaproget
TW200609226A (en) New isobenzoxazinones and their use as ultraviolet light absorbers
ATE533769T1 (de) Als kinaseinhibitoren geeignete pyrrolotriazinverbindungen